Director TitleAgeSince
Director/Board Member - 2010-09-30
Director/Board Member - 2010-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
+1.33%-2.26%+16.81%+67.05% 46.96B
+0.12%-4.02%+52.13%+123.20% 39.63B
-0.64%-2.80%-8.19%+15.25% 12.07B
-0.99%-8.34%+11.63%+69.12% 11.61B
+0.58%0.00%+30.65%+147.62% 9.11B
+0.70%-0.54%+20.67%+40.41% 7.47B
+0.80%+1.69%+45.73%-11.26% 7.18B
-2.54%-1.90%+15.45%+189.85% 6.79B
-0.97%-2.30%-30.37%+24.93% 5.75B
Average +17,989.79%-1.80%+17.17%+74.02% 16.29B
Weighted average by Cap. +0.47%-2.90%+24.45%+81.98%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock